vimarsana.com

Latest Breaking News On - Traci mccarty - Page 6 : vimarsana.com

BioMarin to Participate in Bank of America 2023 Health Care Conference

SAN RAFAEL, Calif., May 4, 2023 /PRNewswire/ BioMarin Pharmaceutical Inc. today announced that Brian Mueller, Executive Vice President, Chief Financial Officer of BioMarin will present at the. | May 4, 2023

United statesMarni kottleLas vegasBrian muellerTraci mccartyHealth care conference onPrnewswire biomarin pharmaceutical incBiomarin pharmaceutical incMarin pharmaceuticalExecutive vice presidentChief financial officerCare conferenceBiomarin pharmaceutical inc stock exchangePress releaseT bmrn us09061g1013

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q1 2023 Earnings Call Transcript

Operator: Welcome to the BioMarin Pharmaceuticals First Quarter Investor Update Call. Hosting the conference call today from BioMarin is Traci McCarty, Group Vice President, Investor Relations.

New yorkUnited statesSaudi arabiaJean jacques bienaimeGeoffrey meachamHenry fuchsGeoff meachamJeff ajerJeffrey ajerHank fuchsPiper sandlerChristopher raymondTraci mccartyBrian muellerSalveen richterGreg guyer

BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues

Growth of VOXZOGO® Accelerated with Rapid Uptake in Japan and Brazil Resulting in Increased Full-year 2023 GuidanceFull-year 2023 Top-line and Bot.

United statesTraci mccartyJean jacques bienaimMarni kottleNational association of statuary health insurance fundsInternational numberCompany asCompany annualBiomarin genzymePrnewswire biomarin pharmaceutical incEuropean commissionExchange commissionDrug administrationBiomarin pharmaceutical incReplay international numberDevelopment expense

BioMarin to Host First Quarter 2023 Financial Results Conference Call and Webcast on Wednesday, April 26, at 4:30pm ET

/PRNewswire/ BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will.

Traci mccartyJean jacques bienaimMarni kottleInternational numberPrnewswire biomarin pharmaceutical incBiomarin pharmaceutical incInternational replay numberMarin pharmaceuticalChief executive officerCanada dial in numberDial in numberCanada replay dial in numberReplay dial in numberBiomarin pharmaceutical inc

BioMarin Provides Update on FDA Review of ROCTAVIAN™ (Valoctocogene Roxaparvovec) Gene Therapy for Adults with Severe Hemophilia A

/PRNewswire/ BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today.

Hank fuchsMarni kottleTraci mccartyDevelopment of biomarinEuropean commissionDrug administrationBiomarin pharmaceutical incExchange commissionWorldwide researchPrnewswire biomarin pharmaceutical incEuropean medicines agencyRobust clinical programTarget action dateMarin pharmaceuticalBiologics license applicationMajor amendment

vimarsana © 2020. All Rights Reserved.